⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8849933 | 1.00 | — | — | |
| SCHEMBL8849170 | 1.00 | — | — | |
| SCHEMBL8849212 | 1.00 | — | — | |
| SCHEMBL8848972 | 1.00 | — | — | |
| SCHEMBL8849675 | 1.00 | — | — | |
| SCHEMBL14252520 | 0.90 | — | — | |
| SCHEMBL2349064 | 0.80 | — | — | |
| SCHEMBL12392488 | 0.80 | — | — | |
| SCHEMBL3336929 | 0.80 | — | — | |
| SCHEMBL14278974 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5674913-A | INSTILLING A PERFLUOROCHEMICAL LIQUID INTO THE TRACHEA TO FILL THE ALVEOLAR SACS TO ENABLE NORMAL BREATHING; REMOVAL OF BREATHING-ASSISTING EQUIPMENT; NO INDUCING OF HYPERINFLATED LUNG SYNDROME; SURFACTANT-DEFICIENT | SYNTHETIC BLOOD INTERNATIONAL, INC. (US) | 1997-10-07 | — | — | US | claimed |
| US-5674913-A | INSTILLING A PERFLUOROCHEMICAL LIQUID INTO THE TRACHEA TO FILL THE ALVEOLAR SACS TO ENABLE NORMAL BREATHING; REMOVAL OF BREATHING-ASSISTING EQUIPMENT; NO INDUCING OF HYPERINFLATED LUNG SYNDROME; SURFACTANT-DEFICIENT | SYNTHETIC BLOOD INTERNATIONAL, INC. (US) | 1997-10-07 | — | — | US | disclosed |